Browse > Article
http://dx.doi.org/10.4062/biomolther.2017.254

Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats  

Yang, Dong Kwon (Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Biosafety Research Institute and Korea Zoonosis Research Institute, Center for Poultry Diseases Control, Chonbuk National University)
Kang, Hyung-Sub (Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Biosafety Research Institute and Korea Zoonosis Research Institute, Center for Poultry Diseases Control, Chonbuk National University)
Publication Information
Biomolecules & Therapeutics / v.26, no.2, 2018 , pp. 130-138 More about this Journal
Abstract
Quercetin and resveratrol are known to have beneficial effects on the diabetes and diabetic complication, however, the effects of combined treatment of these compounds on diabetes are not fully revealed. Therefore, the present study was designed to investigate the combined antidiabetic action of quercetin (QE) and resveratrol (RS) in streptozotocin (STZ)-induced diabetic rats. To test the effects of co-treated with these compounds on diabetes, serum glucose, insulin, lipid profiles, oxidative stress biomarkers, and ions were determined. Additionally, the activities of hepatic glucose metabolic enzymes and histological analyses of pancreatic tissues were evaluated. 50 male Sprague-Dawley rats were divided into five groups; normal control, 50 mg/kg STZ-induced diabetic, and three (30 mg/kg QE, 10 mg/kg RS, and combined) compound-treated diabetic groups. The elevated serum blood glucose levels, insulin levels, and dyslipidemia in diabetic rats were significantly improved by QE, RS, and combined treatments. Oxidative stress and tissue injury biomarkers were dramatically inhibited by these compounds. They also shown to improve the hematological parameters which were shown to the hyperlactatemia and ketoacidosis as main causes of diabetic complications. The compounds treatment maintained the activities of hepatic glucose metabolic enzymes and structure of pancreatic ${\beta}-cells$ from the diabetes, and it is noteworthy that cotreatment with QE and RS showed the most preventive effect on the diabetic rats. Therefore, our study suggests that cotreatment with QE and RS has beneficial effects against diabetes. We further suggest that cotreatment with QE and RS has the potential for use as an alternative therapeutic strategy for diabetes.
Keywords
Diabetes; Quercetin; Resveratrol; Streptozotocin; Glucose;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Del Follo-Martinez, A., Banerjee, N., Li, X., Safe, S. and Mertens-Talcott, S. (2013) Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a. Nutr. Cancer 65, 494-504.   DOI
2 ElAttar, T. M. and Virji, A. S. (1999) Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 10, 187-193.   DOI
3 Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502.
4 Go, H. K., Rahman, M. M., Kim, G. B., Na, C. S., Song, C. H., Kim, J. S., Kim, S. J. and Kang, H. S. (2015) Antidiabetic effects of yam (dioscorea batatas) and its active constituent, allantoin, in a rat model of streptozotocin-induced diabetes. Nutrients 7, 8532-8544.   DOI
5 Gumaa, K. A. and McLean, P. (1972) The kinetic quantitation of ATP: D-glucose 6-phosphotransferases. FEBS Lett. 27, 293-297.   DOI
6 Gupta, D., Raju, J., Prakash, J. and Baquer, N. Z. (1999) Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes Res. Clin. Pract. 46, 1-7.   DOI
7 Igura, K., Ohta, T., Kuroda, Y. and Kaji, K. (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 171, 11-16.
8 Machha, A., Achike, F. I., Mustafa, A. M. and Mustafa, M. R. (2007) Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 16, 442-447.
9 Kulkarni, C. R., Joglekar, M. M., Patil, S. B. and Arvindekar, A. U. (2012) Antihyperglycemic and antihyperlipidemic effect of Santalum album in streptozotocin induced diabetic rats. Pharm. Biol. 50, 360-365.   DOI
10 Kurukulasuriya, R., Link, J. T., Madar, D. J., Pei, Z., Rohde, J. J., Richards, S. J., Souers, A. J. and Szczepankiewicz, B. G. (2003) Prospects for pharmacologic inhibition of hepatic glucose production. Curr. Med. Chem. 10, 99-121.   DOI
11 McLellan, A. C., Thornalley, P. J., Benn, J. and Sonksen, P. H. (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.) 87, 21-29.
12 Oshaghi, E. A., Goodarzi, M. T., Higgins, V. and Adeli, K. (2017) Role of resveratrol in the management of insulin resistance and related conditions: mechanism of action. Crit. Rev. Clin. Lab. Sci. 54, 267-293.   DOI
13 Palsamy, P. and Subramanian, S. (2009) Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chem. Biol. Interact. 179, 356-362.   DOI
14 Palsamy, P. and Subramanian, S. (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim. Biophys. Acta 1812, 719-731.   DOI
15 Rolo, A. P. and Palmeira, C. M. (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 212, 167-178.   DOI
16 Zhou, B., Zou, H. and Xu, G. (2016) Clinical utility of serum cystatin c in predicting diabetic nephropathy among patients with diabetes mellitus: a meta-analysis. Kidney Blood Press. Res. 41, 919-928.   DOI
17 Zhou, M., Wang, S., Zhao, A., Wang, K., Fan, Z., Yang, H., Liao, W., Bao, S., Zhao, L., Zhang, Y., Yang, Y., Qiu, Y., Xie, G., Li, H. and Jia, W. (2012) Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice. J. Proteome Res. 11, 4961-4971.   DOI
18 Piwkowska, A., Rogacka, D., Audzeyenka, I., Jankowski, M. and Angielski, S. (2011) High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes. J. Cell. Biochem. 112, 1661-1672.
19 Rahman, M. M., Lee, S. J., Mun, A. R., Adam, G. O., Park, R. M., Kim, G. B., Kang, H. S., Kim, J. S., Kim, S. J. and Kim, S. Z. (2014) Relationships between blood Mg2+ and energy metabolites/enzymes after acute exhaustive swimming exercise in rats. Biol. Trace Elem. Res. 161, 85-90.   DOI
20 Ramesh, B. and Pugalendi, K. V. (2006) Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J. Med. Food 9, 562-566.   DOI
21 Roslan, J., Giribabu, N., Karim, K. and Salleh, N. (2017) Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats. Biomed. Pharmacother. 86, 570-582.   DOI
22 Saisho, Y., Kou, K., Tanaka, K., Abe, T., Kurosawa, H., Shimada, A., Meguro, S., Kawai, T. and Itoh, H. (2011) Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes. Endocr. J. 58, 315-322.   DOI
23 West, I. C. (2000) Radicals and oxidative stress in diabetes. Diabet. Med. 17, 171-180.   DOI
24 Vessal, M., Hemmati, M. and Vasei, M. (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 135C, 357-364.
25 Vidal-Puig, A. and O'Rahilly, S. (2001) Metabolism. Controlling the glucose factory. Nature 413, 125-126.   DOI
26 Wang, G. G., Lu, X. H., Li, W., Zhao, X. and Zhang, C. (2011) Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid. Based. Complement. Alternat. Med. 2011, 323171.
27 Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053.   DOI
28 Tahrani, A. A., Piya, M. K., Kennedy, A. and Barnett, A. H. (2010) Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol. Ther. 125, 328-361.   DOI
29 Su, H. C., Hung, L. M. and Chen, J. K. (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290, E1339-E1346.   DOI
30 Szkudelski, T. and Szkudelska, K. (2011) Anti-diabetic effects of resveratrol. Ann. N. Y. Acad. Sci. 1215, 34-39.   DOI
31 Zak, B., Epstein, E. and Baginski, E. S. (1977) Determination of liver microsomal glucose-6-phosphatase. Ann. Clin. Lab. Sci. 7, 169-177.
32 Wilson, J. F. (2010) In clinic. Diabetic ketoacidosis. Ann. Intern. Med. 152, ITC1-1, ITC1-2, ITC1-3,ITC1-4, ITC1-5, ITC1-6, ITC1-7, ITC1-8, ITC1-9, ITC1-10, ITC1-11, ITC1-12, ITC1-13, ITC1-14, ITC1-15, table of contents; quiz ITC1-16.
33 Yim, S., Malhotra, A. and Veves, A. (2007) Antioxidants and CVD in diabetes: where do we stand now? Curr. Diab. Rep. 7, 8-13.   DOI
34 Yonamine, C. Y., Pinheiro-Machado, E., Michalani, M. L., Freitas, H. S., Okamoto, M. M., Correa-Giannella, M. L. and Machado, U. F. (2016) Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory. Nutr. Metab. (Lond.) 13, 44.
35 Zamin, L. L., Filippi-Chiela, E. C., Dillenburg-Pilla, P., Horn, F., Salbego, C. and Lenz, G. (2009) Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 100, 1655-1662.   DOI
36 Cersosimo, E., Solis-Herrera, C., Trautmann, M. E., Malloy, J. and Triplitt, C. L. (2014) Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr. Diabetes Rev. 10, 2-42.   DOI
37 American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33, S62-S69.   DOI
38 Arias, N., Macarulla, M. T., Aguirre, L., Milton, I. and Portillo, M. P. (2016) The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue. Eur. J. Nutr. 55, 341-348.
39 Baquer, N. Z., Cascales, M., McLean, P. and Greenbaum, A. L. (1976) Effects of thyroid hormone deficiency on the distribution of hepatic metabolites and control of pathways of carbohydrate metabolism in liver and adipose tissue of the rat. Eur. J. Biochem. 68, 403-413.   DOI
40 Ceriello, A. (2005) Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54, 1-7.   DOI
41 Chen, S., Jiang H., Wu, X. and Fang, J. (2016) Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators Inflamm. 2016, 9340637.